DNAVSFOUR• 28 Days (Normalized)
DNA vs FOUR (Ginkgo Bioworks Holdings Inc. vs Shift4 Payments Inc.)
Showing Closing Date Range from Sep 11 to Oct 9, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
DNA Performance $13
+92.59%
Ginkgo Bioworks Holdings Inc.
Normalized Baseline0.00%
FOUR Performance $40
-11.21%
Shift4 Payments Inc.
Normalized Baseline0.00%
Alpha Spread Margin DNA LEADS
+103.8 pts
DNA outperforming by 103.80 percentage points
DNAFOUR
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
DNA FOUR
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(21 dates)
| Date | DNA Price | DNA Gain (%) | FOUR Price | FOUR Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 09, 2026 | $13.00 | +92.59% | $40.00 | -11.21% | +103.80% |
| Oct 08, 2026 | $11.34 | +68.00% | $39.53 | -12.25% | +80.25% |
| Oct 07, 2026 | $11.47 | +69.93% | $38.99 | -13.45% | +83.38% |
| Oct 06, 2026 | $12.41 | +83.85% | $38.50 | -14.54% | +98.39% |
| Oct 05, 2026 | $14.98 | +121.93% | $37.55 | -16.65% | +138.58% |
| Oct 02, 2026 | $12.35 | +82.96% | $36.17 | -19.71% | +102.67% |
| Oct 01, 2026 | $12.50 | +85.19% | $- | - | |
| Sep 30, 2026 | $12.83 | +90.07% | $- | - | |
| Sep 29, 2026 | $11.96 | +77.19% | $- | - | |
| Sep 28, 2026 | $10.46 | +54.96% | $- | - | |
| Sep 25, 2026 | $10.66 | +57.93% | $38.45 | -14.65% | +72.58% |
| Sep 24, 2026 | $10.25 | +51.85% | $38.16 | -15.29% | +67.14% |
| Sep 23, 2026 | $8.58 | +27.11% | $38.46 | -14.63% | +41.74% |
| Sep 22, 2026 | $9.37 | +38.81% | $39.07 | -13.27% | +52.08% |
| Sep 21, 2026 | $7.98 | +18.22% | $39.37 | -12.61% | +30.83% |
Page 1 of 2